Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients

Condition:   Gastroenteropancreatic Neuroendocrine Tumor Intervention:   Drug: Somatostatin analog Sponsors:   University Hospital, Antwerp;   Erasmus Medical Center;   ZonMw: The Netherlands Organisation for Health Research and Development;   Belgium Health Care Knowledge Centre Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials